Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis Type 1 By Ogkologos - July 1, 2025 667 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KOMET study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR Cancer Research UK reports record levels of investment in its spinouts August 24, 2021 Community Comes Together To Give Terminally Ill Father One Last Christmas... October 18, 2021 Intermittent Fasting March 12, 2021 Treatment for Children with Leukemia Also Effective for Adolescents, Young Adults February 25, 2019 Load more HOT NEWS Quantitative Summary of QoL Data Confirms Immune Checkpoint Inhibitor Therapy Is... What Cancer Caregivers Should Know About Hospice Care at Home: A... Oncology Dietitians Don’t Usually Inquire About Food Insecurity in Cancer Patients,... After a Generous Donor Covered Her Bills, Breast Cancer Survivor Raises...
